American Academy of Dermatology President Seemal R. Desai, MD, FAAD ...

Interim Results from clinical study for cutaneous carcinomas presented at Late-Breaking Research Session Marlborough, ...

Experts stressed the importance of dermatologists engaging in climate advocacy and adopting sustainable practices, as their ...

Two posters presented at the 2025 American Academy of Dermatology Annual Meeting reaffirmed the impact of ruxolitinib cream (Opzelura; Incyte) in atopic dermatitis (AD), while late-breaking ...

Skin care has spawned some of social media’s biggest stars, many of whom have lucrative deals with companies to promote their ...

ORLANDO, FL (March 7, 2025) — Philadelphia-based board-certified dermatologist Susan C. Taylor, MD, FAAD, will begin her one-year term as president of the American Academy of Dermatology at the close ...

March 7, 2025 /PRNewswire/ -- Four new officers and four new board members will be installed immediately upon conclusion of the 2025 Annual Meeting of the American Academy of Dermatology.

The reduction in itch was the greatest contributor to quality-of-life improvement for adolescents and adults with atopic ...

Additionally, the abstracts will be published in an online Journal of the American Academy of Dermatology (JAAD) supplement following the meeting. For more information regarding Castle’s posters ...

Half-life in non-human primates (NHP) of more than 30 days, over three times longer than bimekizumab and expected to support a dose interval of ...

Data demonstrated favorable safety and local tolerability of ZORYVE® (roflumilast) cream 0.15% in adults and children with atopic dermatitis (AD) ...